Literature DB >> 19293134

Renal biopsy in liver transplant recipients.

Aisling O'Riordan1, Neelanjana Dutt, Hugh Cairns, Mohamed Rela, John G O'Grady, Nigel Heaton, Bruce M Hendry.   

Abstract

BACKGROUND: Renal impairment post-liver transplant (LT) is often attributed to calcineurin inhibitors (CNIs). A renal biopsy can be a useful tool but may be complicated in LT recipients. We aimed to determine the clinical scenarios that prompted a decision to perform a renal biopsy in this patient population, to assess histological findings and evaluate patient management and survival and renal outcome.
METHODS: Information on clinical variables and renal histology was extracted from single-centre prospectively compiled databases from 1996 onwards.
RESULTS: Over 2100 adults received an LT in the time period studied, and 54 of these (35 males and 19 females) were referred for renal review. Of these, 43% underwent a renal biopsy. They had a higher creatinine (P = 0.02), a greater deterioration in creatinine over the year prior to review and were more likely to be nephrotic (both P < 0.01). Histological findings included hypertensive changes (44%), CNI nephrotoxicity (48%), IgA nephropathy (9%), membranoproliferative glomerulonephritis (17%), acute tubular necrosis (4%), crescentic glomerulonephritis (4%) and diabetic nephropathy (9%). Major bleeding complications occurred in 17%. Treatment changed in the majority but, it was not significantly different in the two groups. Although initial renal function was worse in the biopsied group, final patient and renal survival did not differ between the two groups.
CONCLUSION: A renal biopsy is a valuable tool in those with renal insufficiency and/or proteinuria and haematuria but the benefits must be weighed against the relatively high complication rate in LT recipients.

Entities:  

Mesh:

Year:  2009        PMID: 19293134     DOI: 10.1093/ndt/gfp112

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

1.  Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients.

Authors:  Alina M Allen; W Ray Kim; Joseph J Larson; Colin Colby; Terry M Therneau; Andrew D Rule
Journal:  Transplantation       Date:  2015-07       Impact factor: 4.939

2.  Role of cytokine gene polymorphisms in acute and chronic kidney disease following liver transplantation.

Authors:  Hideya Kamei; Yasuharu Onishi; Taro Nakamura; Masatoshi Ishigami; Nobuyuki Hamajima
Journal:  Hepatol Int       Date:  2016-03-22       Impact factor: 6.047

Review 3.  INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease.

Authors:  Anil Arora; Ashish Kumar; Narayan Prasad; Ajay Duseja; Subrat K Acharya; Sanjay K Agarwal; Rakesh Aggarwal; Anil C Anand; Anil K Bhalla; Narendra S Choudhary; Yogesh K Chawla; Radha K Dhiman; Vinod K Dixit; Natarajan Gopalakrishnan; Ashwani Gupta; Umapati N Hegde; Sanjiv Jasuja; Vivek Jha; Vijay Kher; Ajay Kumar; Kaushal Madan; Rakhi Maiwall; Rajendra P Mathur; Suman L Nayak; Gaurav Pandey; Rajendra Pandey; Pankaj Puri; Ramesh R Rai; Sree B Raju; Devinder S Rana; Padaki N Rao; Manish Rathi; Vivek A Saraswat; Sanjiv Saxena; Praveen Sharma; Shivaram P Singh; Ashwani K Singal; Arvinder S Soin; Sunil Taneja; Santosh Varughese
Journal:  J Clin Exp Hepatol       Date:  2020-10-09

4.  Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment.

Authors:  Jong Hoon Lee; Yul Hee Cho; Seung Jee Ryu; Sin Seung Kim; Youn Hee Lee; In-Ae Jang; Bum Soon Choi; Jong Young Choi; Dong Goo Kim; Yeong Jin Choi; Chul Woo Yang; Byung Ha Chung
Journal:  Kidney Res Clin Pract       Date:  2013-10-24

5.  Disrupted Renal Mitochondrial Homeostasis after Liver Transplantation in Rats.

Authors:  Qinlong Liu; Yasodha Krishnasamy; Hasibur Rehman; John J Lemasters; Rick G Schnellmann; Zhi Zhong
Journal:  PLoS One       Date:  2015-10-19       Impact factor: 3.240

6.  Hidden pathology of kidney disease after liver transplantation.

Authors:  Yon Su Kim
Journal:  Kidney Res Clin Pract       Date:  2013-11-21

7.  A systematic review of statistical methodology used to evaluate progression of chronic kidney disease using electronic healthcare records.

Authors:  Faye Cleary; David Prieto-Merino; Dorothea Nitsch
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

8.  Renal histopathological lesions after liver transplantation: What can we find besides calcineurin inhibitor-induced nephrotoxicity?

Authors:  Haijiao Jin; Yuehan Wei; Yongbing Qian; Jiang Zhang; Yao Xu; Hang Zhou; Minfang Zhang; Wenyan Zhou; Chaojun Qi; Wei Jin; Shan Mou; Qin Wang; Jianjun Zhang
Journal:  BMC Nephrol       Date:  2022-09-30       Impact factor: 2.585

Review 9.  The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors.

Authors:  Naim Issa; Aleksandra Kukla; Hassan N Ibrahim
Journal:  Arab J Urol       Date:  2012-04-07

Review 10.  Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges.

Authors:  Hsuan Yeh; Chung-Cheng Chiang; Tzung-Hai Yen
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.